G. Aranda et al. / Tetrahedron 57 =2001) 6051±6056
6055
JBX5 Hz, H-2 and H-3), 6.30 81H, s, H-11b). 13C NMR,
found 351.1802. 1H NMR 8200 MHz, CDCl3) d ppm:
0.93, 1.00, 1.24 89H, 3s, CH3-15, -14 and -13), 2.05 and
2.09 86H, 2s, COCH3), 4.77 81H, t, J2.7 Hz, H-1b), 6.94
81H, t, J1.0 Hz, H-11b). 13C NMR, see Table 3.
see Table 3.
4.2.6. 1a-Acetoxy-11a-hydroxy-2,3-dehydroconfertifolin
5b. After crystallization from pentane±EtOAc, mp 183±
22
1868C. [a]D 13078 8c 0.305, CHCl3). HRMS 8CI±
NH3) calc. for C17H26O5 8M11) 324.1811, found
324.1804. IR 8CCl4), nmax 8cm21): 3027, 3013, 2986,
2931, 1760, 1728, 1602, 1465, 1422, 1370, 1264, 1083,
Acknowledgements
L. Moreno gratefully acknowledges CONICYT, Chile
8Research Grant 2990102) for ®nancial support. We want
also to warmly thank Nicole Morin for all HRMS measure-
ments.
1
1019. H NMR 8200 MHz, CD3OD) d ppm: 0.96, 1.04,
1.26 89H, 3s, CH3-15, -14 and -13), 1.98 83H, s, CH3CO),
5.11 81H, d, J1-25.3 Hz, H-1b), 5.68, 5.73, 5.76, 5.79, 5.81,
5.84, 5.91 82H, AB part of an ABX system, between H-2,
H-3 and H-1b, JAB10 Hz, JAX0, and JBX5.3 Hz, H-2
and H-3), 6.0 81H, br.s, H-11b). 13C NMR, see Table 3.
References
4.2.7. 1a,11a-Diacetoxy-2,3-dehydroconfertifolin 5c.
After two crystallizations from pentane±CH2Cl2, mp 142±
1. Azerad, R. In Stereoselective Biocatalysis; Patel, R., Ed.;
Marcel Dekker: New York, 2000; pp. 153±180.
2. Hollinshead, D. M.; Howell, S. C.; Ley, S. V.; Mahon, M.;
Ratcliffe, N. M.; Worthington, P. A. J. Chem. Soc., Perkin
Trans. 1 1983, 1579±1589.
20
1458C. [a]D 12388 8c 0.5, CHCl3). IR 8CCl4), nmax
8cm21): 2979, 2927, 2854, 1786, 1736, 1371, 1242, 1204,
1075, 1018, 985. HRMS 8CI±NH3) calc. for C19H24O6 8M1)
348.1573, found 348.1577. H NMR 8200 MHz, CDCl3) d
1
3. Aranda, G.; Facon, I.; Lallemand, J. Y.; Leclaire, M.; Azerad,
R.; Cortes, M.; Lopez, J.; Ramirez, H. Tetrahedron Lett. 1992,
33, 7845±7848.
ppm: 0.96, 1.08, 1.18 89H, 3s, CH3-15, -14 and -13), 1.98
and 2.09 86H, 2s, COCH3), 4.85 81H, d, J1-25.4 Hz, H-1b),
5.70, 5.75, 5.79, 5.81, 5.83, 5.86 82H, AB part of an ABX
system, between H-2, H-3 and H-1b, JAB9.8 Hz, JAX0,
and JBX5.4 Hz, H-2 and H-3), 6.97 81H, t, J0.75 Hz,
H-11b). 13C NMR, see Table 3.
4. Ramirez, H. E.; Cortes, M.; Agosin, E. J. Nat. Prod. 1993, 56,
762±764.
5. Atta-Ur-Rahman; Choudhary, M. I.; Ata, A.; Alam, M.;
Farooq, A.; Perveen, S.; Shekhani, M. S.; Ahmed, N. J. Nat.
Prod. 1994, 57, 1251±1255.
4.2.8. 1a,11a-Dihydroxyconfertifolin 7a. 68 mg of 5a
were hydrogenated in the presence of PtO2 849 mg) in
EtOAc 84.5 mL) during 6.5 h. After ®ltration through Celite
and two crystallizations from EtOAc±pentane, mp 152±
6. Herlem, D.; Ouazzani, J.; Khuong-Huu, F. Tetrahedron Lett.
1996, 37, 1241±1243.
7. Aranda, G.; Bertranne-Delahaye, M.; Lallemand, J.-Y.;
Azerad, R.; Maurs, M.; Cortes, M.; Lopez, J. J. Mol. Catal:
B.Enzymatic =Special Issue: Biotrans'97) 1998, 5, 255±259.
8. Maurs, M.; Azerad, R.; Cortes, M.; Aranda, G.; Bertranne-
Delahaye, M.; Ricard, L. Phytochemistry 1999, 52, 291±296.
9. Aranda, G.; Lallemand, J.-Y.; Azerad, R.; Maurs, M.; Cortes,
M.; Ramirez, H.; Vernal, G. Synth. Commun. 1994, 24, 2525±
2535.
20
1548C. [a]D 11008 8c 0.95, CH3OH). HRMS 8CI±NH3)
1
calc. for C15H23O4 8M11) 267.1596, found 267.1593. H
NMR 8500 MHz, CD3OD) d ppm: 0.95, 0.98, 1.25 89H,
3s, CH3-15, -14 and -13), 1.21 and 1.74 83H, 2m, H2-3
and H-5), 1.61 and 2.04 82H, 2m, H2-3), 1.66 81H, m,
H-6), 1.92 81H, m, H-6), 2.12 81H, m, H-7a), 2.33 81H,
dd, J7b±7a18 Hz, J7b±6aJ7b±6b5.8 Hz, H-7b), 4.05
81H, br.s, H-1b), 6.30 81H, br.s, H-11b). 13C NMR, see
Table 3.
10. Aranda, G.; Bertranne-Delahaye, M.; Azerad, R.; Maurs, M.;
Â
Cortes, M.; Ramirez, H.; Vernal, G.; Prange, T. Synth.
Commun. 1997, 27, 45±60.
11. Appel, H. H.; Connolly, J. D.; Overton, K. H.; Bond, R. P. M.
J. Chem. Soc. 1960, 4685±4692.
4.2.9. 1a-Acetoxy,11a-hydroxyconfertifolin 7b. Hydro-
genation of 5b 850 mg) in EtOAc 83.5 mL) in the presence
of PtO2 845 mg) during 5 h provided quantitatively a 3:1
mixture of 1a-acetoxy,11a-hydroxy and 1a-hydroxy,11a-
acetoxy derivatives which were not separated by TLC.
Despite repeated crystallization 8CH2Cl2±pentane), a pure
sample of the major constituent 87b) could not be obtained.
HRMS 8CI±NH3) calc. for C17H25O5 8M11) 309.1702,
found 309.1696. 1H NMR 8200 MHz, CDCl3) d ppm:
0.94, 0.98, 1.33 89H, 3s, CH3-15, -14 and -13), 2.07 83H,
s, COCH3), 5.19 81H, t, J2.8 Hz, H-1b), 5.84 81H, d, J
1.85 Hz, H-11b). 13C NMR, see Table 3.
12. Appel, H. H.; Bond, R. P. M.; Overton, K. H. Tetrahedron
1963, 19, 635.
13. Ley, S. V.; Mahon, M. J. Chem. Soc., Perkin 1 1983, 1379±
1381.
14. Fukuyama, Y.; Sato, T.; Miura, I.; Asakawa, Y. Phyto-
chemistry 1985, 24, 1521±1524.
15. 7c was crystallized by slow evaporation of a methanol solu-
tion. A crystal 0.1£0.3£0.4 mm3 in size was recorded on a
PHILIPS PW1100 diffractometer operating the CuKa
radiation. Space group P21. Parameters are a8.50183);
Ê
b13.97984); c7.84782) A; b90.2687)8 and Z2. The
structure was solved by direct methods and re®ned with aniso-
tropic thermal factors 8except for hydrogens) to a ®nal R
6.9% for 1325 observed structure factors. The coordinates
have been deposited with the Cambridge Crystallographic
Data Centre 8CCDC 157588).
4.2.10. 1a,11a-Diacetoxyconfertifolin 7c. Hydrogenation
of 5c 866 mg) in EtOAc 84.5 mL) in the presence of PtO2
845 mg) during 4 h provided quantitatively 7c. After crystal-
20
lization from CH2Cl2±pentane, mp 156±1578C. [a]D
115.88 8c 0.228, CHCl3). IR 8CCl4), nmax 8cm21): 2957,
2933, 1784, 1735, 1374, 1248, 1203, 1046, 1012, 984.
HRMS 8CI±NH3) calc. for C19H27O6 8M11) 351.1806,
16. Fattorusso, E.; Magno, S.; Santacroce, C.; Sica, D.
Tetrahedron 1972, 28, 5993±5997.
17. Lu, Q.; Faulkner, D. J. J. Nat. Prod. 1997, 60, 195±198.